Inogen | INGN - Current Assets


Inogen reported $203.72M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
AngioDynamics USD 172.27M 3.09M Feb/2025
AtriCure USD 301.11M 29.85M Sep/2025
Baxter International USD 6.93B 184M Sep/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.04B 914M Sep/2025
Chart Industries USD 2.86B 72.7M Sep/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Dexcom USD 5.22B 189.3M Sep/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.86B 420.3M Sep/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 23.22B 591M Jun/2025
Orthofix International USD 394.17M 1.66M Sep/2025
Philips EUR 9.93B 654M Dec/2025
ResMed USD 3.82B 193.06M Dec/2025
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 616.94M 2.13M Sep/2025
Teleflex USD 1.99B 262.12M Sep/2025
X T L Biopharmaceuticals USD 1.34M 647K Dec/2024
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025